enGene Inc. is a biotechnology company developing a proprietary non-viral gene therapy platform for localized delivery of nucleic acid payloads to mucosal tissues. The dually derived chitosan (DDX) platform has a high-degree of payload flexibility including DNA and various forms of RNA (siRNA, shRNA, lncRNA etc.) with broad tissue and disease applications

Biotechnology

enGene

enGene's headquarters in Montréal, Canada

Bao Le

Rosemary Mazanet

James C. Sullivan

Martine Bail

Yu Juan Wang

Ryan Daws

Lee Giguere

Shahram Katousian

My Lan Tran

Christine Tosone

Kristine S. Louis

Alex Nichols

Tammy Linback Rn

Daniel Veilleux

Amy Pott

Jason Welch

Tara Place

Lauren Stival Hopfer

Beverly Chase

Kamalpreet Arora

Lili Wang

Richard Glickman

Dennis Langer

Marco Boorsma

Gerry Brunk

The Directors team at enGene strategically oversees various aspects of the company's operations, ensuring the successful development and deployment of their non-viral gene therapy platform. This team coordinates across departments, from clinical development and manufacturing to human resources and finance, to align efforts with the company’s goals and regulatory compliance. They also provide leadership and direction in enhancing technological innovations and operational efficiencies.

Directors

The Leadership Team at enGene is responsible for setting the strategic direction and vision of the company, focusing on advancing its proprietary gene therapy platform. This team collaborates closely on regulatory affairs, scientific development, and medical insights to ensure the successful integration of innovative therapies into clinical practice while driving the company's growth and compliance with industry standards. Their combined expertise in biotechnology, regulatory processes, and medical research plays a crucial role in overseeing enGene's mission to deliver transformative treatments for mucosal diseases.

Leadership Team

The Quality and Regulatory Affairs team at enGene Inc. ensures that all gene therapy products meet rigorous quality standards and comply with regulatory requirements. They manage quality control processes, oversee supplier quality assurance, and facilitate regulatory submissions and interactions with health authorities. This team plays a critical role in maintaining product excellence and securing the necessary approvals for clinical and commercial use.

Quality and Regulatory Affairs

The Research and Development Team at enGene Inc. focuses on advancing the proprietary non-viral gene therapy platform by designing and conducting experiments to optimize the delivery of various nucleic acid payloads to mucosal tissues. The team members work collaboratively on the innovation and application of the DDX platform, aiming to achieve therapeutic breakthroughs for a broad range of diseases.

Research and Development Team

enGene

Org chart

Board & advisors

Teams

Directors

Leadership Team

Quality and Regulatory Affairs

Research and Development Team

Offices

enGene

Org chart

Board & advisors

Teams

Directors

Leadership Team

Quality and Regulatory Affairs

Research and Development Team

Offices

Related companies